Deal of the Day — limited-time pharmacy picks!
Insugen R Refil 100 IU Inj 3 ml Cartridge

Insugen R Refil 100 IU Inj 3 ml Cartridge

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Human insulin (100IU)

Expiry Date: 01/2028

Special offer

Buy at $30.11

$30.11

Inclusive of all taxes

▼

5 Cartridge

About The Product

Used before meals to reduce sugar rise.

Description

Insugen R Refil 100 IU Inj 3 ml Cartridge is a prescription-based medication. It is used in the treatment to reduce the level of blood sugar in the body.

It primarily treats type 1 and type 2 diabetic mellitus. It is used together with a healthy diet and consistent exercise to control blood sugar levels after a meal.

Its active ingredient is Human insulin (100IU), which belongs to the group class of anti diabetic agents. A doctor's Prescription is required to correctly administer the dosage and duration of the medication.

Uses

  • Reduce blood sugar level

Side Effects

Some patients experience acute and some experience mild symptoms. Consult a healthcare professional If any of the symptoms persist or worsen:

  • Low blood sugar (Hypoglycaemia)
  • Lightheadedness
  • Dizziness
  • Anxiety
  • Nervousness
  • Tiredness
  • Feeling hungry
  • Visual disturbances
  • Headache
  • Shaking
  • Sweating
  • Pale skin
  • Skin rashes
  • Pain, redness, swelling at injection site.

How To Use

  • Insugen R Refil 100 IU Inj 3 ml Cartridge should be taken before or after the meal as it is a short acting (regular) human insulin that helps control the rise in blood sugar levels after eating.
  • The dose adjustment must be correctly administered by the healthcare professional.
  • Follow the recommended dosage as prescribed by the doctor.
  • Never overdose or skip the medication as this may increase the risk of side effects which makes the treatment unsafe and less effective.

How It Works

Insugen R Refil 100 IU Inj 3 ml Cartridge increases glucose uptake into cells by activating glucose transporters (GLUT 4).

The medicine reduces the glucose production by the liver and promotes the storage of glucose as glycogen or lowers blood sugar levels.

Safety Advice

Alcohol
Patients should avoid alcohol while taking Insugen R Refil 100 IU Inj 3 ml Cartridge because it interrupt with the treatment and may cause dangerous fluctuations in blood pressure.
Pregnancy
Insugen R Refil 100 IU Inj 3 ml Cartridge is not taken by pregnant women unless prescribed, as careful monitoring is required to manage blood pressure during pregnancy.
Breast Feeding
Women who breastfeed their child should avoid using Insugen R Refil 100 IU Inj 3 ml Cartridge as it may pass into breast milk and affect the baby.
Driving
It is unknown whether Insugen R Refil 100 IU Inj 3 ml Cartridge causes dizziness and reduces vision. For more information, consult the doctor for safety tips.
Kidney
Insugen R Refil 100 IU Inj 3 ml Cartridge is not used by kidney patients without medical supervision because the medicine can interrupt the kidney function.
Liver
Consult a doctor before taking Insugen R Refil 100 IU Inj 3 ml Cartridge if you are a patient of liver cancer, as liver function and effectiveness of the medication.

FAQs

Insugen R Refil 100 IU Inj 3 ml Cartridge should be used by the patient of reduced blood sugar levels in the body.

References

  • Jørgensen, K. H., Hansen, A. K., & Buschard, K. (2000). Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs. Diabetes research and clinical practice, 50(3), 161-167. https://pubmed.ncbi.nlm.nih.gov/32378737/
  • Owens, D. R. (1986). Human insulin: clinical pharmacological studies in normal man. Springer Science & Business Media. https://catalog.nlm.nih.gov/discovery/fulldisplay?docid=alma996129413406676&context=L&vid=01NLM_INST:01NLM_INST&lang=en&adaptor=Local%20Search%20Engine&tab=LibraryCatalog&query=lds56%2Ccontains%2CClinical%20Trials%20as%20Topic%2CAND&mode=advanced&offset=130
  • Pfützner, A., Mann, A. E., & Steiner, S. S. (2002). Technosphere™/Insulin—a new approach for effective delivery of human insulin via the pulmonary route. Diabetes technology & therapeutics, 4(5), 589-594. https://pubmed.ncbi.nlm.nih.gov/12450439/
  • CHRISTIANSEN, J. S., SONNENBERG, G. E., KVERNELAND, A., SCHMITZ, A., CHRISTENSEN, C. K., HERMANSEN, K., ... & DECKERT, T. (1987). Clinical Outcome of Using Insulin at 40 IU/ml and 100 IU/ml in Pump Treatment: Results of a Controlled Multi‐Center Trial. Acta Medica Scandinavica, 222(1), 65-70. https://pubmed.ncbi.nlm.nih.gov/3307309/
  • Boehm, B. O., Home, P. D., Behrend, C., Kamp, N. M., & Lindholm, A. (2002). Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients. Diabetic Medicine, 19(5), 393-399. https://pubmed.ncbi.nlm.nih.gov/12027927/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026